A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps

Diabetes and Metabolism

Volumn 27, Issue 3, 2001, Pages 323-327

  Catargi, B ^a   Breilh, D ^a   Gin, H ^a   Rigalleau, V ^a   Saux, M C ^a   Roger, P ^a   Tabarin, A ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Glycemic control; Hypoglycemia; Insulin pump; Low blood glucose index; Programmability; Randomized study

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; NEUTRAL INSULIN;

ADULT; AGED; ARTICLE; AUTOMATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSSOVER PROCEDURE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MALE; METABOLIC REGULATION; NIGHT; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPOGLYCEMIA; INFUSION PUMPS, IMPLANTABLE; INSULIN INFUSION SYSTEMS; MALE; RISK FACTORS;

EID: 0034936797     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy
3. Pharmacokinetics of continuous subcutaneous insulin infusion
4. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes
5. Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII
6. Subcutaneous insulin infusion: Change in basal infusion rate has no immediate effect on insulin absorption rate
7. Pompes à insuline (Recommandations de I'ALFEDIAM)
8. Establishing & verifying basal rates
9. Assessment of risk for severe hypoglycemia among adults with IDDM: Validation of the low blood glucose index
10. Symmetrization of the blood glucose measurement scale and its applications
11. The physiologic replacement of insulin. An elusive goal
12. Rarity of a marked dawn phenomenon in diabetic subjects treated by continuous subcutaneous insulin infusion
13. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
14. Insulin lispro in CSII. Results of a double-blind crossover study